Triflavin, an Arg-Gly-Asp-containing peptide, prevents platelet plug formation in in vivo experiments

Joen Rong Sheu, Mao Hsiung Yen, Hui Chin Peng, Mei Chi Chang, Tur Fu Huang

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Triflavin, an Arg-Gly-Asp-containing peptide from Trimeresurus flauoviridis snake venom (M1, of 7500 Da) inhibits platelet aggregation through the blockade of fibrinogen binding to activated platelets. The present study demonstrated that the intravenous injection of triflavin (0.1 and 0.25 mg/kg) significantly prolonged the bleeding time about 1.8- to 2.4-fold as compared with control (normal saline) of severed mesenteric arteries in rats, whereas the injection of Gly-Arg-Gly-Asp-Ser (GRGDS) (2-8 mg/kg) failed to increase the bleeding time in this model. Continuous infusion of triflavin (0.08 mg/kg/min) significantly increased the bleeding time about 2.6-fold, and the bleeding time returned to normal within 20 min after the cessation of triflavin infusion. Triflavin (10-20 mg/kg) significantly prolonged the occlusion time of platelet plug formation induced by irradiation of mesenteric venules of fluorescein sodium-pretreated mice. In contrast, trigramin (10-20 mg/kg) and GRGDS (500 and 1000 mg/kg) showed no significant effect. These results suggest that triflavin has an effective antiplatelet effect in vivo and this peptide may be a useful therapeutic agent for arterial thrombosis.

Original languageEnglish
Pages (from-to)231-238
Number of pages8
JournalEuropean Journal of Pharmacology
Volume294
Issue number1
DOIs
Publication statusPublished - Dec 27 1995

Fingerprint

glycyl-arginyl-glycyl-aspartyl-serine
Bleeding Time
Blood Platelets
Peptides
Trimeresurus
Snake Venoms
Mesenteric Arteries
Venules
Fluorescein
Platelet Aggregation
Intravenous Injections
Fibrinogen
triflavin
Thrombosis
Injections

Keywords

  • Bleeding time
  • Fibrinogen receptor antagonist
  • Mesenteric artery
  • RGD (Arg-Gly-Asp)-containing peptide
  • Thrombosis
  • Triflavin

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Triflavin, an Arg-Gly-Asp-containing peptide, prevents platelet plug formation in in vivo experiments. / Sheu, Joen Rong; Yen, Mao Hsiung; Peng, Hui Chin; Chang, Mei Chi; Huang, Tur Fu.

In: European Journal of Pharmacology, Vol. 294, No. 1, 27.12.1995, p. 231-238.

Research output: Contribution to journalArticle

Sheu, Joen Rong ; Yen, Mao Hsiung ; Peng, Hui Chin ; Chang, Mei Chi ; Huang, Tur Fu. / Triflavin, an Arg-Gly-Asp-containing peptide, prevents platelet plug formation in in vivo experiments. In: European Journal of Pharmacology. 1995 ; Vol. 294, No. 1. pp. 231-238.
@article{a4eceb115f9f4b6ca92ae5c2ef3f98b2,
title = "Triflavin, an Arg-Gly-Asp-containing peptide, prevents platelet plug formation in in vivo experiments",
abstract = "Triflavin, an Arg-Gly-Asp-containing peptide from Trimeresurus flauoviridis snake venom (M1, of 7500 Da) inhibits platelet aggregation through the blockade of fibrinogen binding to activated platelets. The present study demonstrated that the intravenous injection of triflavin (0.1 and 0.25 mg/kg) significantly prolonged the bleeding time about 1.8- to 2.4-fold as compared with control (normal saline) of severed mesenteric arteries in rats, whereas the injection of Gly-Arg-Gly-Asp-Ser (GRGDS) (2-8 mg/kg) failed to increase the bleeding time in this model. Continuous infusion of triflavin (0.08 mg/kg/min) significantly increased the bleeding time about 2.6-fold, and the bleeding time returned to normal within 20 min after the cessation of triflavin infusion. Triflavin (10-20 mg/kg) significantly prolonged the occlusion time of platelet plug formation induced by irradiation of mesenteric venules of fluorescein sodium-pretreated mice. In contrast, trigramin (10-20 mg/kg) and GRGDS (500 and 1000 mg/kg) showed no significant effect. These results suggest that triflavin has an effective antiplatelet effect in vivo and this peptide may be a useful therapeutic agent for arterial thrombosis.",
keywords = "Bleeding time, Fibrinogen receptor antagonist, Mesenteric artery, RGD (Arg-Gly-Asp)-containing peptide, Thrombosis, Triflavin",
author = "Sheu, {Joen Rong} and Yen, {Mao Hsiung} and Peng, {Hui Chin} and Chang, {Mei Chi} and Huang, {Tur Fu}",
year = "1995",
month = "12",
day = "27",
doi = "10.1016/0014-2999(95)00530-7",
language = "English",
volume = "294",
pages = "231--238",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Triflavin, an Arg-Gly-Asp-containing peptide, prevents platelet plug formation in in vivo experiments

AU - Sheu, Joen Rong

AU - Yen, Mao Hsiung

AU - Peng, Hui Chin

AU - Chang, Mei Chi

AU - Huang, Tur Fu

PY - 1995/12/27

Y1 - 1995/12/27

N2 - Triflavin, an Arg-Gly-Asp-containing peptide from Trimeresurus flauoviridis snake venom (M1, of 7500 Da) inhibits platelet aggregation through the blockade of fibrinogen binding to activated platelets. The present study demonstrated that the intravenous injection of triflavin (0.1 and 0.25 mg/kg) significantly prolonged the bleeding time about 1.8- to 2.4-fold as compared with control (normal saline) of severed mesenteric arteries in rats, whereas the injection of Gly-Arg-Gly-Asp-Ser (GRGDS) (2-8 mg/kg) failed to increase the bleeding time in this model. Continuous infusion of triflavin (0.08 mg/kg/min) significantly increased the bleeding time about 2.6-fold, and the bleeding time returned to normal within 20 min after the cessation of triflavin infusion. Triflavin (10-20 mg/kg) significantly prolonged the occlusion time of platelet plug formation induced by irradiation of mesenteric venules of fluorescein sodium-pretreated mice. In contrast, trigramin (10-20 mg/kg) and GRGDS (500 and 1000 mg/kg) showed no significant effect. These results suggest that triflavin has an effective antiplatelet effect in vivo and this peptide may be a useful therapeutic agent for arterial thrombosis.

AB - Triflavin, an Arg-Gly-Asp-containing peptide from Trimeresurus flauoviridis snake venom (M1, of 7500 Da) inhibits platelet aggregation through the blockade of fibrinogen binding to activated platelets. The present study demonstrated that the intravenous injection of triflavin (0.1 and 0.25 mg/kg) significantly prolonged the bleeding time about 1.8- to 2.4-fold as compared with control (normal saline) of severed mesenteric arteries in rats, whereas the injection of Gly-Arg-Gly-Asp-Ser (GRGDS) (2-8 mg/kg) failed to increase the bleeding time in this model. Continuous infusion of triflavin (0.08 mg/kg/min) significantly increased the bleeding time about 2.6-fold, and the bleeding time returned to normal within 20 min after the cessation of triflavin infusion. Triflavin (10-20 mg/kg) significantly prolonged the occlusion time of platelet plug formation induced by irradiation of mesenteric venules of fluorescein sodium-pretreated mice. In contrast, trigramin (10-20 mg/kg) and GRGDS (500 and 1000 mg/kg) showed no significant effect. These results suggest that triflavin has an effective antiplatelet effect in vivo and this peptide may be a useful therapeutic agent for arterial thrombosis.

KW - Bleeding time

KW - Fibrinogen receptor antagonist

KW - Mesenteric artery

KW - RGD (Arg-Gly-Asp)-containing peptide

KW - Thrombosis

KW - Triflavin

UR - http://www.scopus.com/inward/record.url?scp=0029610590&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029610590&partnerID=8YFLogxK

U2 - 10.1016/0014-2999(95)00530-7

DO - 10.1016/0014-2999(95)00530-7

M3 - Article

C2 - 8788436

AN - SCOPUS:0029610590

VL - 294

SP - 231

EP - 238

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1

ER -